Concepedia

James Merson

JM

20

Publications

1.8K

Citations

18

H-Index

1988

Active since

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

Pfizer (Canada)

University of Birmingham

Gilead Sciences (United States)

James Merson is an author at Pfizer (United States) specializing in medicine, virology, and immunology.

Top concepts

Publications per year

1988–2016

20

Publications

20

X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes

Risto Lapatto, T. Blundell, Andrew M. Hemmings et al. · Nature · 1989 · 454 citations

, , +12

Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection

Dirk B. Mendel, Chun Y. Tai, Paul A. Escarpe et al. · Antimicrobial Agents and Chemotherapy · 1998 · 254 citations · Full text

Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071

Weixing Li, Paul A. Escarpe, Eugene Eisenberg et al. · Antimicrobial Agents and Chemotherapy · 1998 · 224 citations · Full text

, , +11

Development of Novel Cell Surface CD34-Targeted Recombinant Adenoassociated Virus Vectors for Gene Therapy

Qicheng Yang, Michael Mamounas, Gang Yu et al. · Human Gene Therapy · 1998 · 126 citations

Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 protein.

Andrew D. Wardell, W. Errington, Giuseppe Ciaramella et al. · Journal of General Virology · 1999 · 90 citations

, , +17

Rows per page

1–5 of 20